CNR1; CNR2; | |
NPSR1; | |
ALPL; ALOX12; HSD17B10; NOX4; POLB; | |
ACHE; | |
MET; FLT3; CDK1; PIM1; AXL; KDR; IGF1R; AURKB; | |
TP53; NFKB1; | |
FABP4; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Enzyme_unclassified | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P05186 | CHEMBL5979 |
Enzyme_unclassified | ALOX12 | Arachidonate 12-lipoxygenase | P18054 | CHEMBL3687 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | NOX4 | NADPH oxidase 4 | Q9NPH5 | CHEMBL1250375 |
Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Peptide receptor (family A GPCR) | NPSR1 | Neuropeptide S receptor | Q6W5P4 | CHEMBL5162 |
Protein Kinase | MET | Hepatocyte growth factor receptor | P08581 | CHEMBL3717 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0009987; cellular process | GO:0043066; negative regulation of apoptotic process | 1.886E-07 | 1.956E-04 | ALOX12, AURKB, AXL, CDK1, IGF1R, KDR, NFKB1, PIM1, TP53 |
BP | GO:0050896; response to stimulus | GO:0032496; response to lipopolysaccharide | 5.069E-07 | 3.942E-04 | ALPL, AXL, CNR1, CNR2, CYP1A2, NFKB1 |
BP | GO:0050896; response to stimulus | GO:0010243; response to organonitrogen compound | 1.105E-06 | 6.686E-04 | CDK1, CNR1, CNR2, FLT3, IGF1R, NFKB1, NOX4, TP53 |
BP | GO:0008152; metabolic process | GO:0018108; peptidyl-tyrosine phosphorylation | 1.809E-06 | 9.754E-04 | AXL, FLT3, IGF1R, KDR, MET |
BP | GO:0008152; metabolic process | GO:0046777; protein autophosphorylation | 2.339E-06 | 1.061E-03 | AURKB, FLT3, IGF1R, KDR, PIM1 |
BP | GO:0009987; cellular process | GO:1902533; positive regulation of intracellular signal transduction | 7.160E-06 | 2.598E-03 | AXL, CDK1, CYP1B1, FLT3, KDR, MET, NOX4, TP53 |
BP | GO:0009987; cellular process | GO:0038171; cannabinoid signaling pathway | 7.420E-06 | 2.649E-03 | CNR1, CNR2 |
BP | GO:0040011; locomotion | GO:0030335; positive regulation of cell migration | 7.585E-06 | 2.664E-03 | ALOX12, IGF1R, KDR, MET, NOX4, TP53 |
BP | GO:0050896; response to stimulus | GO:0045471; response to ethanol | 8.308E-06 | 2.827E-03 | CDK1, CNR1, POLB, TP53 |
BP | GO:0009987; cellular process | GO:0051262; protein tetramerization | 2.117E-05 | 5.835E-03 | ACHE, HSD17B10, IGF1R, TP53 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 8.784E-04 | 6.965E-03 | CYP1A2, CYP1B1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04151 | PI3K-Akt signaling pathway | 2.902E-05 | 8.367E-04 | KDR, TP53, MET, NFKB1, IGF1R |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04015 | Rap1 signaling pathway | 7.587E-05 | 8.422E-04 | CNR1, KDR, MET, IGF1R |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04014 | Ras signaling pathway | 1.007E-04 | 1.016E-03 | KDR, MET, NFKB1, IGF1R |
09140 Cellular Processes | 09144 Cellular community - eukaryotes | hsa04510 | Focal adhesion | 1.357E-03 | 8.451E-03 | KDR, MET, IGF1R |
09150 Organismal Systems | 09149 Aging | hsa04211 | Longevity regulating pathway - mammal | 1.451E-04 | 1.239E-03 | TP53, NFKB1, IGF1R |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 1.370E-03 | 8.451E-03 | CYP1B1, IGF1R |
09160 Human Diseases | 09161 Cancers | hsa05202 | Transcriptional misregulation in cancer | 1.299E-06 | 1.442E-04 | FLT3, TP53, MET, NFKB1, IGF1R |
09160 Human Diseases | 09161 Cancers | hsa05206 | MicroRNAs in cancer | 1.495E-05 | 8.295E-04 | PIM1, CYP1B1, TP53, MET, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 3.252E-05 | 8.367E-04 | FLT3, PIM1, NFKB1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE; |
A00-B99: Certain infectious and parasitic diseases | Postherpetic neuralgia | B02.2, G44.847, G53.0 | CNR1; |
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE; |
A00-B99: Certain infectious and parasitic diseases | Human immunodeficiency virus infection | B20-B26 | FLT3; |
A00-B99: Certain infectious and parasitic diseases | Anthelmintic | B89 | ALPL; |
C00-D49: Neoplasms | Liver cancer | C22 | IGF1R; KDR; |
C00-D49: Neoplasms | Late-stage solid tumors | C00-C75, C7A, C7B, D10-D36, D3A | TP53; |
C00-D49: Neoplasms | Gastric cancer | C16 | KDR; |
C00-D49: Neoplasms | Cutaneous Melanoma | C43-C44 | KDR; |
C00-D49: Neoplasms | Thyroid cancer | C73 | KDR; |